[1]JustusLiebigsAnnalenderChemie,1938,vol.536,p.97,108
[1]OrganicProcessResearchandDevelopment,2009,vol.13,p.543-547
[2]JournalofMedicinalChemistry,2008,vol.51,p.5101-5108
[3]JournalofMedicinalChemistry,2003,vol.46,p.3945-3951
[4]JustusLiebigsAnnalenderChemie,1938,vol.536,p.97,108
[5]JustusLiebigsAnnalenderChemie,1938,vol.536,p.97,108
[1]JournalofMedicinalChemistry,2003,vol.46,p.3945-3951
[1]JournalofMedicinalChemistry,2003,vol.46,p.3945-3951
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: Nicotinic acid receptor agonists.
Journal: Journal of medicinal chemistry 20081225
Title: 3-(1H-tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): a partial agonist of the nicotinic acid receptor, G-protein coupled receptor 109a, with antilipolytic but no vasodilatory activity in mice.
Journal: Journal of medicinal chemistry 20080828
Title: Agonist lead identification for the high affinity niacin receptor GPR109a.
Journal: Bioorganic & medicinal chemistry letters 20070901
Title: Pyrazole derivatives as partial agonists for the nicotinic acid receptor.
Journal: Journal of medicinal chemistry 20030828